News

Home/News/Details

Exhibition News

Jiangxi Linquan Capsule will be participating in the 2024 Uzbekistan International Medical and Pharmaceutical Exhibition, TIHE, from April 16th to April 18th. As a leading pharmaceutical company in China, this is an excellent platform for Jiangxi Linquan Capsule to showcase its advanced products and latest technological innovations to a wider audience.

 

The exhibition is expected to attract participants from around the world, including leading pharmaceutical companies, medical practitioners, researchers, and government officials. It will provide an opportunity for Jiangxi Linquan Capsule to establish partnerships with other companies and expand its global reach.

 

Jiangxi Linquan Capsule is known for its high-quality products and state-of-the-art facilities. With a focus on research and development, their products are designed to meet modern-day healthcare needs. The company specializes in the production of traditional Chinese medicine, with a range of products including capsules, tablets, and granules.

 

At the exhibition, Jiangxi Linquan Capsule will display its full range of products and services. The company's representatives will be on hand to provide information about the products and share knowledge about the latest trends in the pharmaceutical industry. They will also be available to answer any questions from attendees.

 

1
2
3
4

 

Jiangxi Linquan Capsule is committed to providing the highest level of healthcare solutions and services to its customers. By participating in the 2024 Uzbekistan International Medical and Pharmaceutical Exhibition, they hope to contribute to the development of the healthcare industry in Uzbekistan and promote the exchange of ideas and information with other companies in the global pharmaceutical industry.

 

In conclusion, the participation of Jiangxi Linquan Capsule in the 2024 Uzbekistan International Medical and Pharmaceutical Exhibition is an exciting opportunity for the company to showcase its products and services to a diverse audience. We look forward to seeing the impact they will make at the exhibition and the partnerships that will be formed.